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Abstract
Background: Considering that adjuvant arthritis is an experimental model of arthritis widely used for preclinical
testing of numerous anti-arthritic agents, which were taken by a large number of patients worldwide, it is of great
interest to investigate the therapeutic action of compounds with anti-inflammatory properties, such as Uncaria
tomentosa extract. Moreover, there are no studies demonstrating the effect of U. tomentosa on the metabolism of
adenine nucleotides published so far. Thus, the purpose of the present study is to investigate the effects of U. tomentosa
extract on E-NTPDase and E-ADA activities in lymphocytes of Complete Freund’s Adjuvant (CFA) arthritis induced rats.
Methods: To evaluate the effect of U. tomentosa extract on the activity of E-NTPDase and ADA in lymphocytes, the rats
were submitted to an experimental adjuvant arthritis model. Peripheral lymphocytes were isolated and E-NTPDase and
E-ADA activities were determined. Data were analyzed by a one- or two-way ANOVA. Post hoc analyses were carried out
by the Student-Newman-Keuls (SNK) Multiple Comparison Test.
Results: E-NTPDase activity was increased in arthritic untreated. Arthritic rats which received U. tomentosa extract,
presented similar results to the control group. However, results obtained for adenosine hydrolysis by E-ADA were
not altered in arthritic rats. U. tomentosa extract did not alter E-NTPDase and E-ADA activity in healthy animals.
Conclusions: The present investigation supports the hypothesis that the increased E-NTPDase activity verified in
arthritic rats might be an attempt to maintain basal levels of ATP and ADP in the extracellular medium, since the
arthritis induction causes tissue damage and, consequently, large amounts of ATP are released into this milieu.
Also, it highlights the possibility to use U. tomentosa extract as an adjuvant to treat arthritis.
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Background
Uncaria tomentosa (Willd.) DC. is a giant vine of the
Rubiaceae family that grows in the Amazon rainforest
and because of its curved thorns it is commonly known
as ‘cat’s claw’ or ‘uña de gato’. This species has been ex-
tensively used among several Peruvian tribes for the
treatment of many diseases, such as arthritis and other
inflammatory disorders [1]. Its active ingredients appear
to be polyphenols (flavonoids, proanthocyanidins, and
tannins), sterols, and alkaloids [2]. Among numerous
U. tomentosa compounds, the mitraphylline is consid-
ered the major alkaloid present in this plant and it might
be, at least partially, responsible for the anti-inflammatory
activity of Uncaria bark extracts [3]. In most studies, its
anti-inflammatory activity has been uniquely attributed to
tetracyclic and pentacyclic oxindole alkaloids. However,
currently available pharmacological data have indicated
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that this biological activity is due to the synergistic action
of several compounds present in this species [4–8].
Arthritis is a systemic inflammatory disease character-
ized by joint pain, stiffness and swelling due to synovial
inflammation, as well as fatigue and limitation in phys-
ical function, and increased morbidity and mortality [9].
It is a debilitating condition occurring at any age, peaking
between the ages of 35 and 50 years and affecting around
1 % of the world population [10]. Adjuvant-induced arth-
ritis is a commonly used model of inflammatory arthritis,
which has an incidence of approximately 90 %, making it
an ideal model to investigate arthritic changes and to
evaluate compounds that may be useful for arthritis treat-
ment [11, 12]. During the inflammatory process in arth-
ritis, the immune and inflammatory responses are active,
and it is well known that an imbalance between pro- and
anti-inflammatory cytokine activities favors the induction
of autoimmunity, chronic inflammation and thereby joint
damage [13].
Extracellular nucleotides are essential molecules for the
onset and maintenance of inflammatory reactions, whereas
they are important signaling molecules [14]. The purinergic
signaling system plays an important role in modulating the
inflammatory and immune responses by extracellular bio-
molecules, such as adenine nucleotides (ATP, ADP and
AMP) and their derived nucleoside adenosine [15]. There is
evidence indicating that high extracellular ATP levels act
through specific cell surface receptors as pro-inflammatory
agents that potentiate the release of pro-inflammatory cyto-
kines [16] from activated lymphocytes [17].
Extracellular ATP and adenosine levels, as well as the
subsequent purinergic signaling, can be physiologically
and dynamically controlled by the action of enzymes
expressed in immune cells [16]. E-NTPDase (CD39) is
the membrane-bound enzyme involved in the break-
down of ATP and ADP to AMP, which is sequentially
hydrolyzed by 5′-nucleotidase to adenosine [18–20].
CD39 was first described as a B lymphocyte activation
marker [21]. In leucocytes, its modulatory effects in cyto-
kines expression, inflammatory response, cell-cell adhesion,
as well as cell proliferation, via modulation of ATP levels in
the pericellular milieu has been demonstrated [4–7]. Ac-
cording to Barankiewicz et al. [22], the presence of CD73
on the external surface of B cells is also related to B cell
development.
E-ADA is another important enzyme that catalyzes the ir-
reversible deamination of adenosine and 2′-deoxyadenosine
to inosine and 2′-deoxyinosine, respectively. Therefore it
contributes to the removal of adenosine from the extracel-
lular compartment [23]. This enzyme has fundamental bio-
logical role in the proliferation and differentiation of
lymphoid cells, particularly T lymphocytes, and maturation
of monocytes [24], performing an important function in the
immune system and inflammatory processes [25].
Considering that adjuvant arthritis is an experimental
model of arthritis widely used for preclinical testing of
numerous anti-arthritic agents, which are either under
preclinical or clinical investigation, it is of clinical interest
to investigate the therapeutic action of compounds with
anti-inflammatory properties, such as Uncaria tomentosa
extract. Moreover, to our knowledge, the current study is
the first one evaluating the effect of U. tomentosa on the
metabolism of adenine nucleotides. Thus, it is relevant to
investigate its effects on the activity of E-NTPDase and




Complete Freund’s Adjuvant (CFA - 0.6 % suspension
of heat-killed Mycobacterium tuberculosis in liquid
paraffin), 5-(N,N-diethylamino) pentyl-3,4,5-trimethox-
ybenzoate (TMB), hexadecyltrimethylammonium bromide
(HTAB), the substrates ATP, ADP, adenosine, as well as
Trizma base, Coomassie Brilliant Blue G and bovine serum
albumin were obtained from Sigma Chemical Co (St. Louis,
MO, USA) and K2HPO4, from Reagen. The acetonitrile
and acetic acid were obtained from JTBarker, the tri-
ethylamine and polyamide from Fluka and ethanol from
Vetec. All the other chemicals used in this experiment were
of the highest purity.
Animals
Twenty eight adult female Wistar rats (200–300 g) were
used in this experiment. Animals were divided into four
groups, namely, control (C); extract (E); arthritis (A); and
arthritis along with extract (A + E). Animals were kept on
a 12-h light/12-h dark cycle, at a temperature of 22 ± 2 °C,
with free access to food and water. The animals were han-
dled according to the guidelines of the Committee on
Brazilian Society of Animal Science Lab [26], in accordance
with international guidelines. Furthermore, this investiga-
tion was approved by the Committee on the Use and Care
of Laboratory Animals of our university (n. 125/2010(2)).
Induction of arthritis
To investigate the effect of the U. tomentosa extract over
the inflammatory process, the adjuvant-induced arthritis
model was used and described by Sauzem et al., [27].
Animals were slightly anesthetized with isoflurane and
100 μL of Complete Freund Adjuvant (CFA - 0.6 % sus-
pension of heat-killed Mycobacterium tuberculosis in li-
quid paraffin) was injected into the right hind paw to
induce arthritis.
HPLC analysis of U. tomentosa extract
Sample extraction was performed using a Unique® ultra-
sound, model USC 5000A, 40 kHz. Chromatographic
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analyses were performed on the Agilent 1100 HPLC sys-
tem and a Zorbax® XDB C-18 column (150 mm× 4.6 mm,
3.5 _m Agilent) at 15 °C. Samples (80 mg) were diluted in
60 % ethanol (10 mL) and subjected to sonication (20 min
at 30 °C). Following this step, 2 mL of sample were passed
through a column containing 200 mg of polyamide, and
the eluate was injected into an HPLC system. Separation
was achieved using gradient elution of water (0.2 % acetic
acid) adjusted to pH 6.9 with triethylamine (A) and aceto-
nitrile (B) at a flow rate of 0.8 mL/min, detection was per-
formed at 245 nm, and the concentrations of alkaloids
were calculated as previously described [28].
Treatment with U. tomentosa extract
The treatment of animals with extract began 15 days
after induction of arthritis by CFA. The U. tomentosa
root dry extract was donated by Herbarium Botanical
Laboratory, PR-Brazil, lot number 991260. The organolep-
tic, physicochemical and microbiological characteristics
were within quality standards; according to the Certificate
of Analysis number 3301/11 presented by supplier. The
extract was prepared daily with distilled water as vehicle
and administered to the groups E and A + E by gavage
twice a day at the dose of 150 mg/kg for 45 days, mimick-
ing the Unha de Gato® phytotherapeutic from Herbarium
Botanical Laboratory, indicated for treatment of patients
with arthritis. Groups C and A received only distilled
water in the same condition.
Evidences of arthritis induction
Evidence of arthritis induction as mechanical sensitivity
and paw thickness of each rat were evaluated briefly be-
fore induction of arthritis by CFA, and then 15 days after
induction. Increased mechanical sensitivity and paw
thickness were considered as markers of the inflamma-
tory process. Moreover, these measurements were made
45 days after U. tomentosa treatment to observe the ef-
fect of U. tomentosa on the inflammatory process. To
observe the development of edema, animals were held
and the right hind paw thickness was measured using a
digital caliper [29]. Additionally, increased paw thickness
was considered as formation of edema. Mechanical allody-
nia was evaluated using the up-and-down method, de-
scribed by Dixon [30], using von Frey filaments. Briefly,
rats were placed in cages with a wire mesh bottom which
allowed full access to the paws. The paw was touched with
1 of a series of 7 von Frey hairs with logarithmic incre-
ments (6, 8, 10, 15, 26, 60 and 100). Von Frey hairs were
applied perpendicularly to the plantar surface with suffi-
cient force to cause slight buckling against the paw, and
held for approximately 2–4 sec. Stimuli were presented at
intervals of several seconds, allowing for apparent reso-
lution of any behavioral responses to previous stimuli. To
evaluate neutrophil infiltration, mieloperoxidase activity
(MPO) was evaluated in paw skin sample, as previously
described [31]. Briefly, sample was homogenized in acetate
buffer (80 mM, pH 5.5) containing 0.5 % HTAB and centri-
fuged at 16.000 xg during 20 min at 4 °C. After, 10 μL of
supernatant were added to 200 μL of acetate buffer and
20 μL of TMB (18.4 mM) and incubated at 37 °C for 3 min.
To stop the reaction, the microplates were taken to the ice
bath and 30 μL of acetic acid were added. The color formed
was assessed at 630 nm and the results were expressed as
optical density per mg of tissue (OD/mg tissue).
Isolation of lymphocytes from blood
Rats were anesthetized with isoflurane and blood was
collected by cardiac puncture. Blood was collected
with 7.2 mg dipotassium EDTA as anticoagulant and
lymphocyte-rich mononuclear cell were isolated from blood
collected with Ethylenediamine tetra acetic acid (EDTA)
and separated on Ficoll-Histopaque density [32]. The per-
centage of lymphocytes was superior to 93 %, as previously
described [33]. The integrity of lymphocytes preparation
was confirmed by determining the lactate dehydrogenase
(LDH) activity in intact and disrupted lymphocytes using
the kinetic method of the Labquest apparatus (Diagnostics
Gold Analyzer). The procedure was repeated before and
after the incubation period. The protocol was carried out
according to the manufacturer’s instructions. Triton X-100
(1 %, final concentration) was used to disrupt the lympho-
cytes preparation. The enzymatic activity is expressed as
units per liter, and one unit (1U) corresponds to 1 μmol of
NADH formed per minute per liter. The resultant lympho-
cytes samples were used immediately for enzymatic assays.
Protein determination
Protein was measured by the Comassie Blue method ac-
cording to Bradford [34] using serum albumin as standard.
E-NTPDase activity determination
E-NTPDase activity in lymphocytes was determined as pre-
viously described by Leal et al. [35], in which the reaction
medium contained 0.5 mM CaCl2, 120 mM NaCl, 5 mM
KCl, 60 mM glucose and 50 mM Tris–HCl buffer at
pH 8.0, with a final volume of 200 μL. Twenty microliters
of the intact mononuclear cells suspended in saline solution
was added to the reaction medium (2–4 μg of protein), and
pre-incubated for 10 min at 37 °C; incubation proceeded
for 70 min. The reaction was initiated by the addition of
substrate (ATP or ADP) at a final concentration of 2.0 mM
and stopped with 200 μL of 10 % trichloracetic acid (TCA).
The released inorganic phosphate (Pi) was assayed by a
method previously described by Chan et al. [36] using
malachite green as colorimetric reagent and KH2PO4 as
standard. Controls were carried out by adding the en-
zyme preparation after TCA addition to correct for
non-enzymatic nucleotide hydrolysis. All samples were
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run in triplicate and the specific activity is reported as
nmol of Pi released/min/mg of protein.
Adenosine deaminase activity determination (ADA)
ADA activity in lymphocytes was measured by the method
of Giusti and Galanti [37], which is based on the direct
measurement of ammonia produced when ADA acts in ex-
cess of adenosine. Briefly, 25 μL of lymphocytes reacted
with 21 mM of the substrate (adenosine), pH 6.5, and incu-
bation was carried out for 1 h at 37 °C. The reaction was
stopped by adding 106 mM and 167.8 mM sodium nitro-
prussiate and hypochlorite solution. Ammonium sulfate
75 μM was used as ammonium standard. All the experi-
ments were performed in triplicate and the values were
expressed in U/L for ADA activity. One unit (1U) of ADA
is defined as the amount of enzyme required to release
1 mmol of ammonia per minute from adenosine at stand-
ard assay conditions.
Separation of blood serum
Rats were anesthetized with isoflurane and blood was
collected by cardiac puncture. The blood samples were
collected in tubes without anticoagulant and after the
clot formation were centrifuged at 1400 g for 15 min at
room temperature. The resultant serum samples were
aliquoted in microtubes and kept on ice until the pu-
rines quantification.
Purine level measurement
The quantitative determination of adenine nucleotides and
adenosine levels were performed in serum by HPLC. At
first, proteins were denatured by the addition of 0.6 mol/L
of percloric acid. Then, all samples were centrifuged
(14,000 × g for 10 min). The obtained supernatants were
neutralized with 4 N KOH and clarified with a second cen-
trifugation (14,000 × g for 15 min). Aliquots of 40 μL were
applied to a reversed-phase HPLC system using a 25 cm
C18 Shimadzu column (Shimadzu, Japan) at 260 nm with a
mobile phase containing 60 mM KH2PO4, 5 mM tetrabuty-
lammonium chloride, pH 6.0, in 30 % methanol according
to a method previously described by Voelter [38]. The
peaks of purines (ATP, ADP, AMP and adenosine) were
identified by their retention times and quantified by com-
parison with standards. Results are expressed as nmoles of
the different compounds per mL of serum.
Statistical analysis
Data were analyzed by a one- or two-way ANOVA. Post
hoc analyses were carried out by the Student-Newman-
Keuls (SNK) Multiple Comparison Test. Purine level
were log-transformed to achieve normal distribution of
data. A probability of P < 0.05 was considered signifi-
cant. All data are expressed as mean ± Standard Error of
the Mean (SEM).
Results
Evidences of arthritis induction and effect of U. tomentosa
extract
As shown in Fig. 1, CFA injection was able to increase
mechanical sensitivity (mechanical allodynia) (Fig. 1a),
paw thickness (Fig. 1b) and MPO activity (Fig. 1c) in
72.4 %, 120.1 % and 35.3 %, respectively, when compared
to baseline, characterizing an arthritic process. After
45 days of treatment, U. tomentosa extract was able to
partially reverse the mechanical allodynia (23.1 ± 2.7 %,
P < 0.01), edema (21.6 ± 5.7 %, P < 0.001) and MPO ac-
tivity (35.5 ± 5.2 %, P < 0.01).
HPLC analysis of U. tomentosa extract
The HPLC analysis of the U. tomentosa root dry extract
used in the present investigation is presented in Fig. 2.
The extract has a content of 0.49 % of pentaciclic and tet-
raciclic oxindole alkaloids. The concentrations of each one
were as follows: uncarine D – 0.05 %, uncarine F – 0.01 %,
mytraphyilline – 0.12 %, rhynchophylline – 0.07 %, isomy-
traphylline– 0.05 %, uncarine C – 0.10 %, isorhyncophyl-
line – 0.05 % and uncarine E – 0.04 %.
E-NTPDase activity determination
Figure 3 shows the effect of oral administration of U.
tomentosa extract on ATP and ADP hydrolysis by E-
NTPDase in lymphocytes of rats submitted to an experi-
mental adjuvant arthritis model. Results of lymphocytes
E-NTPDase activity with ATP as substrate are shown in
Fig. 3a. The hydrolysis of ATP was altered in rats with
arthritis (A) (65.5 nmol of Pi/min/mg of protein; SEM=
4.8; n = 7; P < 0.05), demonstrating that ATP hydrolysis
was increased by 25.7 % when compared to the control
group (C) (48.7 nmol of Pi/min/mg of protein; SEM= 3.2;
n = 7; P < 0.05) and by 28.2 % when compared to the ex-
tract group (E) (47 nmol of Pi/min/mg of protein; SEM=
4.9; n = 7; P < 0.05). However, two-way ANOVA showed
no significant interaction [F(1,15) = 1.458; p = 0.246; n = 7]
among the variables. In addition, results obtained for the
lymphocytes E-NTPDase activity with ADP as substrate are
shown in Fig. 3b, where the ADP hydrolysis was also in-
creased by 32.5 % in the A group (62.4 nmol Pi/min/mg;
SEM= 7.6; n = 7; P < 0.05) when compared to C (42.1 nmol
of Pi/min/mg of protein; SEM= 3.0; n = 7; P < 0.05), in
34.3 % when compared to E group (41.0 nmol of Pi/min/
mg of protein; SEM= 2.9; n = 7; P < 0.05) and in 22 % when
compared to A + E group (48.7 nmol of Pi/min/mg of pro-
tein; SEM= 2.7; n = 7; P < 0.05). Two-way ANOVA showed
no significant interaction [F(1,13) = 2.606; p = 0.130; n = 7].
The results of lymphocytes E-NTPDase activity in the
group E with both ATP (47.0 nmol of Pi/min/mg of
protein; SEM= 4.9; n = 7; P < 0.05) and ADP (41.0 nmol of
Pi/min/mg of protein; SEM= 2.9; n = 7; P < 0.05) as sub-
strate were similar to ATP (48.7 nmol of Pi/min/mg of









































































Fig. 1 Evidence of arthritis induction and the effect of U. tomentosa treatment (150 mg/kg, 2 times/day, v.o.) for 45 days on the inflammatory process
induced by CFA. Mechanical sensitivity (a) and paw edema (b) before (Basal) and after intraplantar injection (saline or CFA), as well as (c) MPO activity.
“+” and “*” represent statistical difference in relation to control and arthritic group, respectively (P < 0.05). Bars represent means ± SEM. One Way
ANOVA followed by Student Newman Keuls (SNK)
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protein; SEM = 3.2; n = 7; P < 0.05) and ADP hydrolysis
in control group (42.1 nmol of Pi/min/mg of protein;
SEM= 3.0; n = 7; P < 0.05), showing that in healthy rats
the extract did not alter the E-NTPDase activity.
Adenosine deaminase activity determination (ADA)
Results obtained for adenosine hydrolysis by E-ADA are
shown in Fig. 4. The adenosine hydrolysis was not al-
tered. The groups showed no significant alterations in
the E-ADA activity when adenosine was used as sub-
strate. Two-way ANOVA showed no significant inter-
action [F(1,15) = 1.572, p = 0.229, n = 7].
Purine level measurement
Purine levels in serum were measured by HPLC and
were showed in Table 1. Levels of ATP, ADP, AMP and
adenosine showed no significant alterations in the A
group when compared to control. The levels of these
nucleotides and nucleoside were also normal in the E
group when compared to control, showing that the extract
did not interfere in the purine level. However, in the A + E
group, the level of ATP was decreased by 14.4 % when
compared to C and A groups and in 12.7 % comparing to E
group, whereas ADP levels were increase by 7.2 %, 4.6 %
and 7.2 % regarding to C, E, and A groups, respectively.
The adenosine levels in in the A + E group were also de-
creased by 17.8 % in comparison to control.
Discussion
Experimental animal models of chronic diseases allow a
better understanding of the physiopathological processes
and also the evaluation of potential new therapies. Based
on that, the model of arthritis induced by CFA in rats is
widely used in the research of new therapies for chronic
inflammatory arthropathies, such as rheumatoid arthritis
[39]. Cat’s claw (Uncaria tomentosa) has been widely used
for the treatment of arthritis, rheumatism and other inflam-
matory diseases due to its well known anti-inflammatory ef-
fects [39–41]. This plant contains a series of secondary
metabolites, such as oxindole alkaloids, polyphenols
(flavonoids, proanthocyanidins, tannins), quinovic acid
glycosides, polyhydroxylated triterpenes and saponins,
but its anti-inflammatory activity is related to more
than one metabolite acting in synergy [4, 5, 42, 43].
Here, the HPLC analysis revealed that mitraphylline
was the preponderant alkaloid present in the U. tomen-
tosa extract used for this research. In fact, Rojas-Duran
et al. [3] reported that the major alkaloid of U. tomentosa
was mytraphylline and evaluated its biological relevance
demonstrating that it was able to impair the liberation of
the interleukins 1α, 1β, 4, 17 and TNF-α, key molecules
involved in inflammatory responses. Since the inflamma-
tory action is closely associated to the immune process
[44], benefits of this plant to the immune system, such as
in purinergic signaling present in lymphocytes, could also
be expressed as an anti-inflammatory action. However, a
direct relationship between the components of this plant
and purine nucleotides has not yet been reported in the
literature.
In the present study, we induced arthritis in animals by
the use of CFA and the inflammatory process was con-
firmed through the measurement of increased paw thick-
ness, mechanical thresholds and MPO activity (neutrophil
marker), which characterizes an arthritic process. After
that, we analyzed if U. tomentosa extract would be able to
reverse this process, and it showed to be partially effective.
Similar results were also observed with carrageenan-
induced paw edema demonstrating that both hydro-
Fig. 2 HPLC fingerprint analysis of root dry extract from U. tomentosa. Uncarine D (1), uncarine F (2), mytraphyilline (3), rhynchophylline (4),
isomytraphylline (5), uncarine C (6), isorhyncophylline (7) and uncarine E (8)
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alcoholic and aqueous extract have anti-inflammatory ac-
tivity by decreasing the carrageenan-induced increase in
paw volume when compared with control rats [44–46].
Human tests with U. tomentosa were carried out in pa-
tients with osteoarthritis and rheumatoid arthritis and
demonstrated that it was able to reduce pain, morning
stiffness and swelling joints [47–49].
Extensive tissue damage in inflammatory processes may
lead to a significant increase in the levels of purine and pyr-
imidine nucleotides within the involved sites, probably con-
tributing to the amplification of the inflammatory reaction
[50]. Extracellular ATP can act as a damage-associated
molecular pattern, given that it is normally confined to
intracellular sites but can be released at high levels follow-
ing cell lysis, infection, or via regulated efflux. ATP released
into the extracellular space can modulate the immune re-
sponse through its capacity to bind and activate multiple
nucleotide receptor family members [51, 52]. In addition,
the purinergic system is also composed by a complex of
ectoenzymes including E-NTPDase and E-ADA that are re-
sponsible for extracellular nucleotide hydrolysis.
The results of the present study showed an increased
E-NTPDase activity in rats with arthritis when compared
to control animals corroborating with Becker et al. [53]







































































Fig. 3 ATP (a) and ADP (b) hydrolysis in lymphocytes of Complete Freund’s Adjuvant (CFA)- induced arthritis rats and treated for 45 days with
Uncaria tomentosa extract in the dose of 150 mg/kg, 2 times/day. Enzyme specific activities are reported as nmol of Pi released/min/mg of
protein. Groups: C (control), E (extract), A (arthritis) and A + E (arthritis + extract). Bars represent mean ± S.E.M. (a,b) Indicates a significant P < 0.05,
with n = 7 (one-way ANOVA-Newman-Keuls Multiple Comparison Test)
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which found increased E-NTPDase activity in platelets
of patients with arthritis. According to a study previ-
ously published by our research group, the E-NTPDase
activity (both ATP and ADP substrate) in lymphocytes
was also altered in patients with RA. The ATP hydrolysis
presented a two-fold increase, while ADP hydrolysis was
80 % increased when compared to the control group.
[54]. Moreover, many other studies have shown that the
E-NTPDase and E-ADA have significant roles in im-
mune response. Alterations in their activities have been
observed in some autoimmune diseases such as multiple
sclerosis, lupus and diabetes [55–57]. Increased activity
of E-NTPDase leads to increased ATP and ADP hydrolysis
and, as a compensatory mechanism, leads to the mainten-
ance of their appropriate levels, since high concentrations
of ATP in the extracellular medium activate the pro-
inflammatory purinergic P2X7 receptors and contributes to
tissue damage and inflammation [58].
Since these enzymes act in a cascade, we can suggest
that the 5′-nucleotidase activity in arthritic rats could be
also increased, resulting in a greater amount of adeno-
sine in the extracellular medium to compensate the pro-
inflammatory effects of ATP. However, in these arthritic
animals, the levels of ATP, ADP, AMP and adenosine are
normal in the extracellular medium as well as E-ADA
activity. We can assume that adenosine is being pro-
duced in excess by the supposed increased activity of 5′-
nucleotidase. This adenosine could be binding to specific
receptors expressed on the cell surface exercising its anti-
inflammatory function and maintaining the levels of adeno-
sine normal on extracellular medium. Thus, adenosine acts
as a negative feedback signal to counteract ATP-mediated
immune stimulation, preventing uncontrolled inflammation
and decreasing the collateral damage to healthy tissues
[59]. The anti-inflammatory properties of U. tomentosa
have been described, hence we evaluated the effect of the


















Fig. 4 Adenosine hydrolysis in lymphocytes of Complete Freund’s Adjuvant (CFA)-induced arthritis rats and treated for 45 days with Uncaria tomentosa
extract in the dose of 150 mg/kg, 2 times/day. Enzyme activities are reported as U/L. Groups: C (control), E (extract), A (arthritis) and A+ E (arthritis +
extract). Bars represent mean ± S.E.M. (a,b) Indicates a significant P< 0.05, with n = 7 (one-way ANOVA-Newman-Keuls Multiple Comparison Test)
Table 1 Purine levels in arthritic rats serum and treated for 45 days with Uncaria tomentosa extract
C E A A + E
(log of nmol/ml) (log of nmol/ml) (log of nmol/ml) (log of nmol/ml)
ATP 1.04 ± 0.003a 1.02 ± 0.01a 1.04 ± 0.02a 0.89 ± 0.01b
ADP 1.25 ± 0.002a 1.28 ± 0.01a 1.25 ± 0.01a 1.34 ± 0.001b
AMP 1.00 ± 0.005a 1.05 ± 0.008a 1.04 ± 0.008a 1.02 ± 0.02a
Adenosine 1.35 ± 0.001a 1.29 ± 0.02ab 1.33 ± 0.01ab 1.11 ± 0.08b
Adenine nucleotides and adenosine levels measurement in serum of Complete Freund’s Adjuvant (CFA)-induced arthritis rats and treated for 45 days with Uncaria
tomentosa extract (150 mg/kg; 2 times/day). Purine levels measurement were log-transformed and are reported as log of nmol/ml. Groups: C (control), E (extract),
A (arthritis) and A + E (arthritis + extract). Bars represent mean ± S.E.M
(a,b) Indicates difference among the groups, P < 0.05 with n = 7 (two-way ANOVA-Newman-Keuls Multiple Comparison Test)
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U. tomentosa dry extract on the metabolism of adenine nu-
cleotides. In healthy animals treated with the extract, the
activities of E-NTPDase and E-ADA remained at basal
levels, what was also confirmed by serum purine levels,
which were in normal concentration in the extracellular
medium.
In arthritic rats treated with U. tomentosa dry extract, the
increase on the E-NTPDase activity was prevented, while
the purine levels on serum showed decreased ATP levels
and increased ADP levels. It seems that low-level purinergic
signaling induced by nucleotides at decreased concen-
trations, modulates ongoing inflammatory and immune
responses by P2 receptors [60]. At low concentration, extra-
cellular ATP possesses affinity for P2Y receptor subtype on
the surfaces of lymphocytes. These purinergic receptors,
when stimulated, develop a down-modulation of pro-
inflammatory cytokines and stimulate the Th2 immune
response, leading to the production of anti-inflammatory
cytokines, protection from oxidative damage and down-
production of oxygen radicals in whole blood [16]. P2Y re-
ceptor signaling may therefore be an important stop signal
to prevent excessive stimulation of inflammation and avoid
conditions that might favor autoimmunity [61].
Among the various classes of chemical constituents
found in U. tomentosa plant, oxindole alkaloids are
regarded as the most important [43]. The alkaloid profile
in U. tomentosa is important because of its pharmaco-
logical properties and because the pentacyclic oxindole al-
kaloids are directly associated with immunostimulatory
properties [62]. The anti-inflammatory activity of trad-
itional extracts made from U. tomentosa is well docu-
mented [63–65]. Mitraphylline is the most ubiquitous
alkaloid being present in Uncaria species [62], being also
the major compound present in our lot of U. tomentosa
extract. Mitraphylline is considered as a new lead com-
pound for the development of anti-inflammatory treat-
ment, being the most chemical effective component and
responsible for suppression of inflammation parameters.
In one previous study, this compound inhibited around
50 % of the release of pro-inflammatory interleukins, and
its activity was similar to dexamethasone [3]. Therefore,
these metabolites are certainly contributing to decrease
the inflammatory process and regulate the purinergic sig-
naling in this data.
Therefore, in this model, these metabolites probably
contribute to decrease the inflammatory process and
regulate the purinergic signaling. No changes were ob-
served in the ADA activity, but a decrease in adenosine
levels was observed in serum of the arthritic rats that re-
ceived U. tomentosa extract. Corroborating our results, a
study previously published by our research group [52] has
showed that the level of adenosine in serum of RA pa-
tients was also decreased. In addition, ADP levels showed
to be increased in this same group. It is possible that the
adenylate kinase (EC 2.7.4.3) could be activated in an at-
tempt to reconstitute the pool of ADP. As proposed by
Yegutkin et al. [66], an opposite pathway could lead to the
recovery of adenine nucleotides, since adenylate kinase
was identified as another key player in the metabolism of
circulating ADP. This extracellular ADP could be linking
itself to P2Y receptor, the adenine-nucleotide-preferring
receptors mainly responding to ADP, and leading the anti-
inflammatory response.
Conclusion
In summary, our data demonstrate that the U. tomentosa
extract was able to reduce partially the mechanical
thresholds, paw thickness and MPO activity in a model
of induced arthritis. In addition, the extract was able to
prevent the increase on the E-NTPDase activity in lym-
phocytes of rats submitted to an experimental adjuvant
arthritis model. In view of this, U. tomentosa extract had
an actual effect against arthritis and for the first time we
demonstrate that the purinergic signaling is involved in
these responses.
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